Division of Speech Pathology, School of Health and Rehabilitation Sciences, The University of Queensland, St Lucia, QLD, 4072, Australia.
Centre for Functioning and Health Research, Queensland Health, Level 3, Centro Buranda, Ipswich Rd, PO Box 6053, Buranda, QLD, 4102, Australia.
Dysphagia. 2022 Jun;37(3):567-577. doi: 10.1007/s00455-021-10307-2. Epub 2021 May 8.
This study explored associative relationships between radiotherapy dose volumes delivered to the dysphagia aspiration risk structures (DARS) and swallowing physiological disturbance at 3 months post treatment in a homogenous cohort of patients who received (chemo)radiotherapy ((C)RT) for oropharyngeal head and neck cancer (HNC). Participants(n = 53) were a subgroup of patients previously recruited as part of a prospective randomised trial, and had undergone physiological swallowing assessment using videofluroscopic swallowing study (VFSS) at 3 months post (C)RT. The extended oral cavity (EOC), supraglottic larynx (SGL), glottic larynx (GL), cricopharyngeal inlet (CI), and pharyngeal constrictor muscles (PCM) were contoured as per international consensus guidelines and dose volume histograms (DVHs) were generated for each structure. Each DVH was analysed to reveal mean, maximum and partial radiotherapy doses of V, V and V for each structure. Physiological swallowing function on VFSS was rated using the Modified Barium Swallow Impairment Profile (MBSImP). A binary logistic regression model was used to establish associative relationships between radiotherapy dose to the DARS and physiological changes within the swallowing mechanism. Structures that received the largest volumes of radiotherapy dose were the PCM and SGL. Significant relationships were found between the proportion of the EOC, SGL, GL and PCMs that received radiotherapy doses > 40 Gy, > 50 Gy and > 60 Gy and the likelihood of a moderate-severe physiological swallowing impairment (on the MBSImP). Whilst the current study was exploratory in nature, these preliminary findings provide novel evidence to suggest structure-specific associative relationships between radiotherapy dose and impacts to corresponding swallow physiology in patients with oropharyngeal HNC.
本研究旨在探讨接受头颈部下咽癌(HNC)放疗(放化疗)的同质患者队列中,放疗剂量体积与吞咽生理障碍之间的关联。该研究的参与者(n=53)是先前作为前瞻性随机试验一部分招募的患者亚组,他们在放化疗后 3 个月接受了视频荧光透视吞咽研究(VFSS)的生理吞咽评估。根据国际共识指南,对扩展口腔(EOC)、声门上喉(SGL)、声门喉(GL)、环咽肌入口(CI)和咽缩肌(PCM)进行了轮廓描绘,并为每个结构生成了剂量体积直方图(DVH)。分析每个 DVH 以揭示每个结构的 V、V 和 V 的平均、最大和部分放疗剂量。VFSS 上的生理吞咽功能使用改良吞咽障碍评分(MBSImP)进行评分。使用二元逻辑回归模型来确定 DARS 的放疗剂量与吞咽机制内生理变化之间的关联。接受最大放疗剂量的结构是 PCM 和 SGL。EOC、SGL、GL 和 PCM 中接受放疗剂量>40Gy、>50Gy 和>60Gy 的比例与中度至重度生理吞咽障碍的可能性之间存在显著关系(MBSImP)。虽然本研究具有探索性,但这些初步发现提供了新的证据,表明头颈部下咽癌患者的放疗剂量与相应吞咽生理之间存在特定结构的关联。